More success ahead

Article Excerpt

INTUITIVE SURGICAL $365.98 (Nasdaq symbol ISRG; SI Rating: Average) (515-507-5000; www.intuitivesurgical.com; Shares outstanding: 39.2 million; Market cap: $14.3 billion; No dividends paid) has more than doubled for us since we first recommended the stock at $150 last June. The company makes the “da Vinci,” a computerized surgical system for use in heart surgery and other procedures. The da Vinci is safer and far less invasive than regular surgery. It also cuts patient recovery time and post-operative discomfort. In the latest quarter, Intuitive’s revenue climbed 74.4%, to $328.6 million from $188.4 million a year earlier. Earnings per share jumped 205.6%, to $2.20 from $0.72. Intuitive should earn $7.75 a share this year, up 27.7% from $6.07 last year. Many hospitals cut equipment spending in the recession. Now, the economic recovery should spur da Vinci sales. More hospitals are also using robots to perform surgery, largely because of Intuitive’s successful marketing. At current prices, the stock may be vulnerable to any negative news. But we feel…